Status:
NOT_YET_RECRUITING
Therapeutic Monitoring of Antibiotics in Intensive Care Patients: a Cohort Study PopTDM-ICU
Lead Sponsor:
Poitiers University Hospital
Conditions:
Intensive Care Unit
Antibiotic Therapy
Eligibility:
All Genders
18+ years
Brief Summary
Intensive care patients are exposed to serious infections. Mortality linked to these infections remains high and antibiotic therapy treatment optimization is one of the key points of therapeutic succe...
Eligibility Criteria
Inclusion
- Patient ≥ 18 year-old.
- Patient hospitalized in intensive care,
- Patient receiving an antibiotic for sepsis or septic shock
- Patient or family member who does not object to participating in the study
Exclusion
- Patient at risk of death, for a cause other than infectious, within 48 hours following the introduction of antibiotic therapy.
- Patient receiving antibiotic treatment for antibiotic prophylaxis.
- Patients benefiting from enhanced protection, namely: minors, persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social establishment, adults under legal protection.
- Pregnant and / or lactating women.
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2028
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT05367011
Start Date
September 1 2022
End Date
September 1 2028
Last Update
August 4 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.